WAY-214156
![]() | |
Identifiers | |
---|---|
| |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C19H10N2O3 |
Molar mass | 314.300 g·mol−1 |
3D model (JSmol) | |
| |
InChI
|
WAY-214156 is a synthetic nonsteroidal estrogen that acts as a highly selective agonist of the ERβ.[1][2] It is 100-fold selective for the ERβ over the ERα with an IC50 of 4.2 nM (compare to estradiol with IC50 values of ~3–4 nM for both the ERα and ERβ).[1] The drug is less selective for the ERβ than is prinaberel (ERB-041, WAY-202041), another selective ERβ agonist, but is more potent in comparison.[1] WAY-214156 may produce anti-inflammatory effects via the ERβ and has been proposed as a potential treatment for inflammatory conditions such as rheumatoid arthritis.[1][3]
See also[]
- 8β-VE2
- Diarylpropionitrile
- ERB-196
- FERb 033
- WAY-166818
- WAY-200070
References[]
- ^ a b c d Cvoro A, Tatomer D, Tee MK, Zogovic T, Harris HA, Leitman DC (2008). "Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes". J. Immunol. 180 (1): 630–6. doi:10.4049/jimmunol.180.1.630. PMID 18097065.
- ^ Serock, Michelle; Wells, Amanda; Khalil, Raouf (2008). "Modulators of Vascular Sex Hormone Receptors and their Effects in Estrogen-Deficiency States Associated with Menopause". Recent Patents on Cardiovascular Drug Discovery. 3 (3): 165–186. doi:10.2174/157489008786263970. ISSN 1574-8901. PMID 18991792.
- ^ Roman-Blas JA, Castañeda S, Cutolo M, Herrero-Beaumont G (2010). "Efficacy and safety of a selective estrogen receptor β agonist, ERB-041, in patients with rheumatoid arthritis: a 12-week, randomized, placebo-controlled, phase II study". Arthritis Care & Research. 62 (11): 1588–93. doi:10.1002/acr.20275. PMID 20556817. S2CID 19511497.
Categories:
- Phenols
- Nitriles
- Selective ERβ agonists
- Synthetic estrogens
- Genito-urinary system drug stubs